A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

University of Buffalo, Buffalo

University of Pennsylvania, Philadelphia

Wake Forest, Winston-Salem

Duke University, Durham

Jacksonville Center for Clinical Research, Jacksonville

New Generation of Medical Research, Hialeah

Amavita Health, Miami

Cleveland Clinic, Cleveland

Chicago Medical Research, Hazel Crest

Methodist Medical Center of Illinois, Peoria

Washington University, St Louis

Louisiana Heart Center, Slidell

Oklahoma Heart Hospital, Oklahoma City

UT Southwestern, Dallas

UCLA, Torrance

Invivocure LLC, Van Nuys

National Institute of Clinical Research, Huntington Beach

FOMAT, Oxnard

Ash Research Clinic, Brick